十七烷基硫酸酯钠盐 | 5910-79-2

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机硫酸及其衍生物
• 中文名称: 十七烷基硫酸酯钠盐
• 英文名称: sodium heptadecyl sulfate
• 英文别名: sodium heptadecyl sulphate；sodium;heptadecyl sulfate
• CAS: 5910-79-2
• 化学式: C₁₇H₃₅O₄S*Na
• 分子量: 358.518
• InChiKey: HHURSJAUVYNJBT-UHFFFAOYSA-M

物化性质

• 物理描述：
  OtherSolid

计算性质

• 辛醇/水分配系数(LogP)：
  2.34
• 重原子数：
  23
• 可旋转键数：
  16
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  74.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  十七烷基硫酸酯钠盐 以 1,4-二氧六环 、 吡啶 为溶剂， 反应 3.0h， 以0.8 mg的产率得到1-十七烷醇
  参考文献：
  名称：

  New Bioactive Sulfated Metabolites from the Mediterranean Tunicate Sidnyum turbinatum

  摘要：

  In addition to the known sodium 3,7,11,15-tetramethylhexadeca-1,19-diyl sulfate (4), the BuOH extract of the Mediterranean tunicate Sidnyum turbinatum was shown to contain four new metabolites: 1-heptadecanyl sulfate (1), 1-octadecanyl sulfate (2), sodium (2S)-2,6,10,14-tetramethylpentadeca-1,18- diyl sulfate (3), and 1-hexyl sulfate (5). Their structures were determined by spectroscopic and chemical methods. Compounds 1-5 exhibited in vitro antiproliferative activity estimated on the WEHI 164 cell line.

  DOI：

  10.1021/np000438c

文献信息

• Silicone Vesicles Containing Actives
  申请人：Lin Shaow Burn

  公开号：US20080226708A1

  公开（公告）日：2008-09-18

  Processes are disclosed for preparing silicone vesicle compositions and emulsions containing silicone vesicles, the compositions prepared therefrom, and formulated personal and healthcare products containing the silicone vesicles and emulsions compositions.

  本发明公开了制备含有硅脂囊泡的乳液和硅脂囊泡组合物的工艺，以及由此制备的组合物和含有硅脂囊泡和乳液组合物的个人保健产品和医疗保健产品的配方。
• CHEMICALLY STABLE AND OROMUCOSALLY ABSORBABLE GEL COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM
  申请人：MUCODEL PHARMA LLC

  公开号：US20160038406A1

  公开（公告）日：2016-02-11

  An oromucosally absorbable liquid composition for administration to a human patient comprises one liquid containing a pH-sensitive pharmaceutically active together with one or more optional suitable pharmaceutical excipients in a first compartment; and a second liquid at pH greater than 5 containing a buffer or alkaline components together with one or more optional suitable pharmaceutical excipients in a second distinct compartment; the first and second compartments maintaining separation of the first and second liquids during storage and allowing for mixing of the two liquids to form an oromucosally absorbable composition at the point of use

  一种可口服吸收的液体组合物，用于给人类患者使用，包括第一隔室中的一种液体，该液体含有一个pH敏感的药物活性成分，以及一个或多个可选的适宜的药物辅料；以及第二隔室中的一个pH大于5的液体，该液体含有缓冲剂或碱性成分以及一个或多个可选的适宜的药物辅料，第一和第二隔室在储存期间保持第一和第二液体的分离，并允许在使用时混合两种液体以形成可口服吸收的组合物。
• Animal feed supplements containing antibiotic trans-BM 123-gamma and process for making same
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0003644A1

  公开（公告）日：1979-08-22

  The invention relates to animal feed supplements containing antibiotic trans-BM123. Such supplements may be economically obtained by adding to a fermentation whole harvest mash containing antibiotic trans-BM123, or to a filtered fermentation broth containing antibiotic BM123, at a suitable acid pH, a complexing agent selected from synthetic tanning agents, alkali metal alkyl sulfates and dioctyl sulfosuccinate salts, whereby to precipitate out a complex of the antibiotic with said complexing agent; and recovering the precipitated complex. These complexes aid in increasing the growth rate and feed efficiency when fed to arm animals, either alone or in combination with carriers.

  本发明涉及含有反式 BM123 抗生素的动物饲料补充剂。在适当的酸性 pH 值下，向含有抗生素 trans-BM123 的发酵全收醪或含有抗生素 BM123 的过滤发酵液中加入选自合成鞣剂、碱金属烷基硫酸盐和磺基琥珀酸二辛酯盐的络合剂，从而沉淀出抗生素与所述络合剂的络合物，并回收沉淀的络合物，可以经济地获得这种补充剂。这些复合物在单独或与载体结合喂养臂部动物时，有助于提高生长速度和饲料效率。
• Enhanced aqueous chemiluminescent systems
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0096749A1

  公开（公告）日：1983-12-28

  Aqueous chemiluminescent systems are found to have improved chemiluminescence due to presence of surfactants in minor amounts.

  水性化学发光体系由于含有少量的表面活性剂，其化学发光效果有所改善。
• Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
  申请人：Armour Pharmaceutical Company

  公开号：EP0197554A2

  公开（公告）日：1986-10-15

  A method for treating a biological or pharmaceutical product to inactivate viruses and pyrogens therein comprising the steps of adsorbing said product onto a solid phase; treating the adsorbed product with a virus or pyrogen inactivating agent; separating the solid phase and quantitatively removing the residual inactivating agent therefrom; and recovering said product.

  一种处理生物或药物产品以灭活其中病毒和热原的方法，包括以下步骤：将所述产品吸附到固相上；用病毒或热原灭活剂处理吸附的产品；分离固相并定量去除其中残留的灭活剂；以及回收所述产品。